New Product Launches Drives Global Radiofrequency ablation devices Market

The global radiofrequency ablation devices market is anticipated to grow at a CAGR of 1.5% during the forecast period (2021-2027). The new and innovative RF ablation devices to support minimally invasive surgeries are a key factor driving the growth of the global radiofrequency ablation devices market. The key companies across the globe are highly inclined towards the adoption of different growth strategies including capacity expansion, mergers and acquisitions, new product launches, and product innovation to remain competitive in the marketplace. The various product launches of the key players are as follows:

Browse the full report description of "Global Radiofrequency Ablation (RF) Devices Market Size, Share & Trends Analysis Report By Type (Customer Loyalty, Employee Loyalty, Channel Loyalty), By End-User Industry (BFSI, Travel & Hospitality, Retail, Other) Forecast Period 2021-2027" at https://www.omrglobal.com/industry-reports/radiofrequency-ablation-rf-devices-market

• In November 2020, Abbott Laboratories has launched the IonicRF Generator. Iconic RF is a US FDA approved device to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system. The IonicRF Generator is a radiofrequency ablation device that uses heat to target specific nerves and block pain signals from reaching the brain.
• In February 2019, Medtronic Plc has launched the new Accurian radio frequency (RF) ablation system in the US, following 510(k) clearance from the country’s regulatory authority. With this launch the company has expanded its minimally invasive therapy portfolio. The new device is suitable for standard, pulsed and enhanced procedures. It has internally-cooled probes to create a lesion of various shapes, sizes and volumes.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered- 

o By Component

o By Application

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Medtronic plc, Abbott Laboratories, Inc., Boston Scientific Corp., AngioDynamics, Inc., and Johnson & Johnson Services, Inc .

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Radiofrequency Ablation Devices Market Report Segment

By Component 

• Catheter System
• Generator
• Accessories

By Application

• Oncology
• Cardiology
• Pain Management
• Others

Global Radiofrequency Ablation Devices Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa

To learn more about this report request a free sample copy @  https://www.omrglobal.com/request-sample/radiofrequency-ablation-rf-devices-market